TrialAmerican journal of respiratory and critical care medicine2023

Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial.

Paul McNally et al.PubMed ↗Publisher ↗

No numbers read from the abstract.